FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease
FDA fully approves Leqembi, first drug to slow progression of Alzheimer's diseasehttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
The FDA has approved a drug for people in the early stages of Alzheimer’s disease. CBS News’ chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit. source
